These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 26460589)
1. Resveratrol Increases Anti-Proliferative Activity of Bestatin Through Downregulating P-Glycoprotein Expression Via Inhibiting PI3K/Akt/mTOR Pathway in K562/ADR Cells. Wang L; Wang C; Jia Y; Liu Z; Shu X; Liu K J Cell Biochem; 2016 May; 117(5):1233-9. PubMed ID: 26460589 [TBL] [Abstract][Full Text] [Related]
2. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway. Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633 [TBL] [Abstract][Full Text] [Related]
3. Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR. Zhang Y; Qu XJ; Liu YP; Yang XH; Hou KZ; Teng YE; Zhang JD Ai Zheng; 2009 Feb; 28(2):97-9. PubMed ID: 19550116 [TBL] [Abstract][Full Text] [Related]
4. The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism. Chiarini F; Del Sole M; Mongiorgi S; Gaboardi GC; Cappellini A; Mantovani I; Follo MY; McCubrey JA; Martelli AM Leukemia; 2008 Jun; 22(6):1106-16. PubMed ID: 18385752 [TBL] [Abstract][Full Text] [Related]
5. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells. Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283 [TBL] [Abstract][Full Text] [Related]
6. Chabamide induces cell cycle arrest and apoptosis by the Akt/MAPK pathway and inhibition of P-glycoprotein in K562/ADR cells. Ren J; Xu Y; Huang Q; Yang J; Yang M; Hu K; Wei K Anticancer Drugs; 2015 Jun; 26(5):498-507. PubMed ID: 25714087 [TBL] [Abstract][Full Text] [Related]
7. In vitro anti-leukemia activity of dual PI3K/mTOR inhibitor Voxtalisib on HL60 and K562 cells, as well as their multidrug resistance counterparts HL60/ADR and K562/A02 cells. Zhang L; Wang Z; Khishignyam T; Chen T; Zhou C; Zhang Z; Jin M; Wang R; Qiu Y; Kong D Biomed Pharmacother; 2018 Jul; 103():1069-1078. PubMed ID: 29710665 [TBL] [Abstract][Full Text] [Related]
8. Dual PI3K/mTOR inhibitor NVP‑BEZ235 decreases the proliferation of doxorubicin‑resistant K562 cells. Li J; Wang X; Ma C; Xu S; Xu M; Yang J; Wang R; Xue L Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 34223631 [TBL] [Abstract][Full Text] [Related]
9. The Hsp90 inhibitor SNX-2112, induces apoptosis in multidrug resistant K562/ADR cells through suppression of Akt/NF-κB and disruption of mitochondria-dependent pathways. Wang R; Shao F; Liu Z; Zhang J; Wang S; Liu J; Liu H; Chen H; Liu K; Xia M; Wang Y Chem Biol Interact; 2013 Sep; 205(1):1-10. PubMed ID: 23777986 [TBL] [Abstract][Full Text] [Related]
10. Baicalin induces apoptosis in leukemia HL-60/ADR cells via possible down-regulation of the PI3K/Akt signaling pathway. Zheng J; Hu JD; Chen YY; Chen BY; Huang Y; Zheng ZH; Liu TB Asian Pac J Cancer Prev; 2012; 13(4):1119-24. PubMed ID: 22799292 [TBL] [Abstract][Full Text] [Related]
11. Enhancement effect of P-gp inhibitors on the intestinal absorption and antiproliferative activity of bestatin. Huo X; Liu Q; Wang C; Meng Q; Sun H; Peng J; Ma X; Liu K Eur J Pharm Sci; 2013 Nov; 50(3-4):420-8. PubMed ID: 23981338 [TBL] [Abstract][Full Text] [Related]
12. Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signaling. He X; Wang Y; Zhu J; Orloff M; Eng C Cancer Lett; 2011 Feb; 301(2):168-76. PubMed ID: 21168265 [TBL] [Abstract][Full Text] [Related]
13. Methotrexate-bestatin interaction: involvement of P-glycoprotein and organic anion transporters in rats. Zhu Y; Meng Q; Wang C; Liu Q; Huo X; Zhang A; Sun P; Sun H; Li H; Liu K Int J Pharm; 2014 Apr; 465(1-2):368-77. PubMed ID: 24530518 [TBL] [Abstract][Full Text] [Related]
14. Decreased expression of nucleophosmin/B23 increases drug sensitivity of adriamycin-resistant Molt-4 leukemia cells through mdr-1 regulation and Akt/mTOR signaling. Wang L; Chen B; Lin M; Cao Y; Chen Y; Chen X; Liu T; Hu J Immunobiology; 2015 Mar; 220(3):331-40. PubMed ID: 25457413 [TBL] [Abstract][Full Text] [Related]
15. HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K/Akt signaling pathway. Wang H; Jia XH; Chen JR; Yi YJ; Wang JY; Li YJ; Xie SY Int J Oncol; 2016 Dec; 49(6):2529-2537. PubMed ID: 27779650 [TBL] [Abstract][Full Text] [Related]
16. The prosurvival role of autophagy in resveratrol-induced cytotoxicity in GH3 cells. Zhang X; Xu W; Su J; Chu M; Jin H; Li G; Tan C; Wang X; Wang C Int J Mol Med; 2014 Apr; 33(4):987-93. PubMed ID: 24534837 [TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity, apoptosis induction and downregulation of MDR-1 expression by the anti-topoisomerase II agent, salvicine, in multidrug-resistant tumor cells. Miao ZH; Tang T; Zhang YX; Zhang JS; Ding J Int J Cancer; 2003 Aug; 106(1):108-15. PubMed ID: 12794765 [TBL] [Abstract][Full Text] [Related]
18. Chaetominine reduces MRP1-mediated drug resistance via inhibiting PI3K/Akt/Nrf2 signaling pathway in K562/Adr human leukemia cells. Yao J; Wei X; Lu Y Biochem Biophys Res Commun; 2016 May; 473(4):867-873. PubMed ID: 27038543 [TBL] [Abstract][Full Text] [Related]
19. Targeting P-glycoprotein and SORCIN: Dihydromyricetin strengthens anti-proliferative efficiency of adriamycin via MAPK/ERK and Ca Sun Y; Wang C; Meng Q; Liu Z; Huo X; Sun P; Sun H; Ma X; Peng J; Liu K J Cell Physiol; 2018 Apr; 233(4):3066-3079. PubMed ID: 28681913 [TBL] [Abstract][Full Text] [Related]
20. Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: role of COX-2 and MDR-1. Arunasree KM; Roy KR; Anilkumar K; Aparna A; Reddy GV; Reddanna P Leuk Res; 2008 Jun; 32(6):855-64. PubMed ID: 18083230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]